In pancreatic cancer, ABCG2 [34], ABCC1, ABCC5 [35], and ABCA8 [36] have been specifically reported to be associated with gemcitabine resistance, whereas additional ABC transporters are widely expressed in chemoresistant PDAC cells [37]. Here, ABCG2 is linked to pancreatic neoplasm.